Literature DB >> 16859302

GFscore: a general nonlinear consensus scoring function for high-throughput docking.

Stéphane Betzi1, Karsten Suhre, Bernard Chétrit, Françoise Guerlesquin, Xavier Morelli.   

Abstract

Most of the recent published works in the field of docking and scoring protein/ligand complexes have focused on ranking true positives resulting from a Virtual Library Screening (VLS) through the use of a specified or consensus linear scoring function. In this work, we present a methodology to speed up the High Throughput Screening (HTS) process, by allowing focused screens or for hitlist triaging when a prohibitively large number of hits is identified in the primary screen, where we have extended the principle of consensus scoring in a nonlinear neural network manner. This led us to introduce a nonlinear Generalist scoring Function, GFscore, which was trained to discriminate true positives from false positives in a data set of diverse chemical compounds. This original Generalist scoring Function is a combination of the five scoring functions found in the CScore package from Tripos Inc. GFscore eliminates up to 75% of molecules, with a confidence rate of 90%. The final result is a Hit Enrichment in the list of molecules to investigate during a research campaign for biological active compounds where the remaining 25% of molecules would be sent to in vitro screening experiments. GFscore is therefore a powerful tool for the biologist, saving both time and money.

Entities:  

Mesh:

Year:  2006        PMID: 16859302     DOI: 10.1021/ci0600758

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  9 in total

1.  Are predefined decoy sets of ligand poses able to quantify scoring function accuracy?

Authors:  Oliver Korb; Tim Ten Brink; Fredrick Robin Devadoss Victor Paul Raj; Matthias Keil; Thomas E Exner
Journal:  J Comput Aided Mol Des       Date:  2012-01-10       Impact factor: 3.686

2.  Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein.

Authors:  Stéphane Betzi; Audrey Restouin; Sandrine Opi; Stefan T Arold; Isabelle Parrot; Françoise Guerlesquin; Xavier Morelli; Yves Collette
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

3.  Inhibition of bacterial virulence: drug-like molecules targeting the Salmonella enterica PhoP response regulator.

Authors:  Yat T Tang; Rong Gao; James J Havranek; Eduardo A Groisman; Ann M Stock; Garland R Marshall
Journal:  Chem Biol Drug Des       Date:  2012-03-21       Impact factor: 2.817

4.  CSAR benchmark exercise of 2010: combined evaluation across all submitted scoring functions.

Authors:  Richard D Smith; James B Dunbar; Peter Man-Un Ung; Emilio X Esposito; Chao-Yie Yang; Shaomeng Wang; Heather A Carlson
Journal:  J Chem Inf Model       Date:  2011-08-29       Impact factor: 4.956

5.  Prediction of N-Methyl-D-Aspartate Receptor GluN1-Ligand Binding Affinity by a Novel SVM-Pose/SVM-Score Combinatorial Ensemble Docking Scheme.

Authors:  Max K Leong; Ren-Guei Syu; Yi-Lung Ding; Ching-Feng Weng
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

Review 6.  Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges.

Authors:  Isabella A Guedes; Felipe S S Pereira; Laurent E Dardenne
Journal:  Front Pharmacol       Date:  2018-09-24       Impact factor: 5.810

7.  Virtual interactomics of proteins from biochemical standpoint.

Authors:  Jaroslav Kubrycht; Karel Sigler; Pavel Souček
Journal:  Mol Biol Int       Date:  2012-08-08

Review 8.  Machine-learning scoring functions to improve structure-based binding affinity prediction and virtual screening.

Authors:  Qurrat Ul Ain; Antoniya Aleksandrova; Florian D Roessler; Pedro J Ballester
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2015-08-28

9.  Applying Machine Learning to Ultrafast Shape Recognition in Ligand-Based Virtual Screening.

Authors:  Etienne Bonanno; Jean-Paul Ebejer
Journal:  Front Pharmacol       Date:  2020-02-19       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.